Sumitomo Mitsui DS Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-22,408	Closed	-$877K	–	802
2018 Q4	$877K	Sell	22,408 -2,455	-10%	-$106K	0.02%	492
2018 Q3	$1.36M	Buy	24,863 +2,667	+12%	+$182K	0.02%	450
2018 Q2	$1.84M	Sell	22,196 -762	-3%	-$58.8K	0.03%	376
2018 Q1	$1.53M	Buy	22,958 +1,599	+7%	+$92.3K	0.02%	419
2017 Q4	$1.1M	Buy	+21,359	New	+$1.53M	0.02%	493

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's ONCE Position: Q1 2019 in Review

Sumitomo Mitsui DS Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 22,408 shares — an estimated $877K sold.

Sumitomo Mitsui DS Asset Management first reported a position in ONCE in Q4 2017 and held it in 5 quarters. The position peaked at $1.84M in Q2 2018. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

Sumitomo Mitsui DS Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Sumitomo Mitsui DS Asset Management sold 22,408 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $877K.
Sumitomo Mitsui DS Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 5 quarters.
Sumitomo Mitsui DS Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $1.84M in Q2 2018.
199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q1 2019, filed 7 May 2019.